CALSADA CRISPINA (Chief Financial Officer) received a stock award from REGULUS THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/10/2025ACC: 0000950170-25-004272
Officer· Chief Financial Officer
Since Aug 2019
+83.50K
Net shares
Net buyer
$112.3K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
83.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+62.50K
Price / share
$1.36
Trade value
$85K
% of position
1080.9%
1/9/2025
5.78K→68.28K
Common Stock
Direct
Shares
+21K
Price / share
$1.30
Trade value
$27.30K
% of position
30.8%
1/9/2025
68.28K→89.28K
Total
Net shares
+83.50K
Net value
$112.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2025 | A · Award | +62.50K | $1.36 | $85K | 1080.9% | 5.78K | 68.28K |
| Common Stock Direct | 1/9/2025 | A · Award | +21K | $1.30 | $27.30K | 30.8% | 68.28K | 89.28K |
| Total | +83.50K | $112.30K | ||||||
Derivative Transactions0
No derivative transactions reported